为您找到相关结果约500个

你是不是要搜索 期刊JCO：基线皮质醇激素姑息治疗和PD-1抑制剂治疗非小细胞肺癌疗效 点击跳转

JCO Turns 40

Nanobodies targeting the interaction interface of programmed death receptor 1 (PD-1)/PD-1 ligand 1 (PD-1/PD-L1)

Regulation of PD-1/PD-L1 pathway and resistance to PD-1/PD-L1 blockade

In vitro Interactions of Chicken Programmed Cell Death 1 (PD-1) and PD-1 Ligand-1 (PD-L1)

Programmed Death 1 (PD-1) and PD-1 Ligand (PD-L1) Expression in Chronic Apical Periodontitis

Enhancing Value Together Through JCO Oncology Practice

PD-1/PD-L1 in disease

Therapeutic PD-L1 antibodies are more effective than PD-1 antibodies in blocking PD-1/PD-L1 signaling

Bis(benzonitrile) dichloroplatinum (II) interrupts PD-1/PD-L1 interaction by binding to PD-1

PD-1 blockade in subprimed CD8 cells induces dysfunctional PD-1(+)CD38(hi) cells and anti-PD-1 resistance

PD-1/PD-L1 in cardiovascular disease

Combination Strategies PD-1/PD-L1 Antagonists

Basal cell carcinoma: PD-L1/PD-1 checkpoint expression and tumor regression after PD-1 blockade

JCO Flashback: Trastuzumab Monotherapy for HER2-Positive Breast Cancer (2002)

High PD-1/PD-L1 Checkpoint Interaction Infers Tumor Selection and Therapeutic Sensitivity to Anti-PD-1/PD-L1 Treatment

为您找到相关结果约500个

共500条页码: 1/34页15条/页